A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease
M Hardin,M H Cho,M-L McDonald,E Wan,D A Lomas,H O Coxson,W MacNee,J Vestbo,J C Yates,A Agusti,P M A Calverley,B Celli,C Crim,S Rennard,E Wouters,P Bakke,S P Bhatt,V Kim,J Ramsdell,E A Regan,B J Make,J E Hokanson,J D Crapo,T H Beaty,C P Hersh,ECLIPSE and COPDGene Investigators,COPDGene Investigators—clinical centers,James Crapo,Edwin Silverman,Barry Make,Elizabeth Regan,Terri Beaty,Nan Laird,Christoph Lange,Michael Cho,Stephanie Santorico,John Hokanson,Dawn DeMeo,Nadia Hansel,Craig Hersh,Peter Castaldi,Merry-Lynn McDonald,Emily Wan,Megan Hardin,Jacqueline Hetmanski,Margaret Parker,Marilyn Foreman,Brian Hobbs,Robert Busch,Adel El-Bouiez,Dandi Qiao,Eitan Halper-Stromberg,Ferdouse Begum,Sungho Won,Brittney Fredericksen,Sharon Lutz,David A Lynch,Harvey O Coxson,MeiLan K Han,Eric A Hoffman,Stephen Humphries,Francine L Jacobson,Philip F Judy,Ella A Kazerooni,John D Newell,James C Ross,Raul San Jose Estepar,Berend C Stoel,Juerg Tschirren,Eva van Rikxoort,Bram van Ginneken,George Washko,Carla G Wilson,Mustafa Al Qaisi,Teresa Gray,Alex Kluiber,Tanya Mann,Jered Sieren,Douglas Stinson,Joyce Schroeder,Edwin Van Beek,Robert Jensen,Douglas Everett,Anna Faino,Matt Strand,Carla Wilson,John E Hokanson,Jennifer Black-Shinn,Gregory Kinney,Katherine Pratte,Jeffrey Curtis,Carlos Martinez,Perry G Pernicano,Nicola Hanania,Philip Alapat,Venkata Bandi,Mustafa Atik,Aladin Boriek,Kalpatha Guntupalli,Elizabeth Guy,Amit Parulekar,Arun Nachiappan,Francine Jacobson,R Graham Barr,Byron Thomashow,John Austin,Belinda D'Souza,Gregory D N Pearson,Anna Rozenshtein,Neil MacIntyre,H Page McAdams,Charlene McEvoy,Joseph Tashjian,Robert Wise,Robert Brown,Karen Horton,Nirupama Putcha,Richard Casaburi,Alessandra Adami,Janos Porszasz,Hans Fischer,Matthew Budoff,Dan Cannon,Harry Rossiter,Amir Sharafkhaneh,Charlie Lan,Christine Wendt,Brian Bell,Gloria Westney,Eugene Berkowitz,Russell Bowler,David Lynch,Richard Rosiello,David Pace,Gerard Criner,David Ciccolella,Francis Cordova,Chandra Dass,Robert D'Alonzo,Parag Desai,Michael Jacobs,Steven Kelsen,Victor Kim,A James Mamary,Nathaniel Marchetti,Aditti Satti,Kartik Shenoy,Robert M Steiner,Alex Swift,Irene Swift,Gloria Vega-Sanchez,Hrudaya Nath,Mark Dransfield,William Bailey,J Michael Wells,Surya Bhatt,Joe Ramsdell,Paul Friedman,Xavier Soler,Andrew Yen,Alejandro Cornellas,John Newell,Brad Thompson,MeiLan Han,Ella Kazerooni,Fernando Martinez,Joanne Billings,Tadashi Allen,Frank Sciurba,Divay Chandra,Joel Weissfeld,Carl Fuhrman,Jessica Bon,Antonio Anzueto,Sandra Adams,Diego Maselli-Caceres,Mario E Ruiz,J Bourbeau,M Fitzgerald,P Hernández,K Killian,R Levy,F Maltais,D O'Donnell,J Krepelka,D Quinn,M Kosnik,Palma de Mallorca,Y Feschenko,V Gavrisyuk,L Yashina,D Singh,J Wedzicha,A Anzueto,S Braman,R Casaburi,G Giessel,M Gotfried,G Greenwald,N Hanania,D Mahler,B Make,C Rochester,P Scanlon,D Schuller,F Sciurba,A Sharafkhaneh,T Siler,E Silverman,A Wanner,R Wise,H Coxson,L Edwards,D Lomas,R Tal Singer,J Yates,P Calverley,B Miller,R Tal-Singer
DOI: https://doi.org/10.1038/tpj.2015.65
Abstract:Short-acting β2-agonist bronchodilators are the most common medications used in treating chronic obstructive pulmonary disease (COPD). Genetic variants determining bronchodilator responsiveness (BDR) in COPD have not been identified. We performed a genome-wide association study (GWAS) of BDR in 5789 current or former smokers with COPD in one African-American and four white populations. BDR was defined as the quantitative spirometric response to inhaled β2-agonists. We combined results in a meta-analysis. In the meta-analysis, single-nucleotide polymorphisms (SNPs) in the genes KCNK1 (P=2.02 × 10(-7)) and KCNJ2 (P=1.79 × 10(-7)) were the top associations with BDR. Among African Americans, SNPs in CDH13 were significantly associated with BDR (P=5.1 × 10(-9)). A nominal association with CDH13 was identified in a gene-based analysis in all subjects. We identified suggestive association with BDR among COPD subjects for variants near two potassium channel genes (KCNK1 and KCNJ2). SNPs in CDH13 were significantly associated with BDR in African Americans.The Pharmacogenomics Journal advance online publication, 27 October 2015; doi:10.1038/tpj.2015.65.